Načítá se...
A126 SERUM ADALIMUMAB LEVELS IN CROHN DISEASE
AIMS: Tests measuring serum adalimumab levels are not widely available. We aim to evaluate whether serum adalimumab levels correlate with disease severity in patients with Crohn disease. Additionally, as the test is expensive, we aim to see if clinical and biochemical markers can be used as a surrog...
Uloženo v:
| Vydáno v: | J Can Assoc Gastroenterol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6508221/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.126 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|